← Leaderboards
Mehrdad Mazlumzadeh
Mayo Clinic Coll Of Medicine, Rochester
$695
Attributed
$695
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$695 · 2
By mechanism
M01$695 · 2
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- Vijay H Shah$27,167,769
- Aminah Jatoi$17,973,141
- Virginia M Miller$9,622,525
- Michael L Camilleri$18,731,842
- Robert A. Rizza$75,563,326
Others in their field
Top investigators on “Temporal Arteritis”
- Cornelia M Weyand · Mayo Clinic Rochester$10,157,473
- Ravi Mahalingam · University Of Colorado Denver$4,954,133
- Randall J. Cohrs · University Of Colorado Denver$2,240,899
- Maria Acena Nagel · University Of Colorado Denver$2,186,546
- Moshe Arditi · Cedars-Sinai Medical Center$2,011,020
- David Beck · New York University School Of Medicine$1,935,224
Research focus
Temporal ArteritisHuman SubjectHuman Therapy EvaluationIntravenous AdministrationClinical ResearchDosageGlucocorticoidsHormone TherapyClinical TrialsPatient Oriented ResearchDrug Administration Rate /DurationDrug Adverse Effect
Grant awards (4)
High Dose Pulse Intravenous GC Infusion as the Initial Treatment of GCA$695
M01 · FY2004 · RR
PULSE IV GLUCOCORTICOID INFUSION AS INITIAL TREATMENT OF GIANT CELL ARTERITIS$0
M01 · FY2002 · RR
PULSE IV GLUCOCORTICOID INFUSION AS INITIAL TREATMENT OF GIANT CELL ARTERITIS$0
M01 · FY2001 · RR
PULSE IV GLUCOCORTICOID INFUSION AS INITIAL TREATMENT OF GIANT CELL ARTERITIS$0
M01 · FY2000 · RR